Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin + Daptomycin vs Cefazolin + Vancomycin for Vascular Surgery Prophylaxis
NCT01612052Phase 4Unknown
- Sponsor
- CAMC Health System
- Start
- May 2011
- Primary completion
- Mar 2013
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daptomycin in Staphylococcus aureus infection, sponsored by CAMC Health System. Status: unknown.
02
Drugs
daptomycin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT01612052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612052.